April 13, 2013

Men1 mouse studies claim pre-clinical proof-of-concept for gene replacement therapy in pituitary NETs.

Clinical and pre-clinical studies of neuroendocrine tumours (NETs) in multiple endocrine neoplasia type 1 (MEN1), and evaluation of MEN1 gene replacement therapy for MEN1-associated NETs.
-Gerard Walls, Paul Newey, et al.
Endocrine Abstracts (2013) 31 YEP1.1 | DOI:10.1530/endoabs.31.YEP1.1

No comments:

Post a Comment